Invention Grant
- Patent Title: GLA monotherapy for use in cancer treatment
-
Application No.: US16416723Application Date: 2019-05-20
-
Publication No.: US10993956B2Publication Date: 2021-05-04
- Inventor: Carlos V. Paya Cuenca , Jan Henrik Ter Meulen
- Applicant: IMMUNE DESIGN CORP.
- Applicant Address: US WA Seattle
- Assignee: IMMUNE DESIGN CORP.
- Current Assignee: IMMUNE DESIGN CORP.
- Current Assignee Address: US WA Seattle
- Agent Nichole M. Valeyko; Anna L. Cocuzzo
- Main IPC: A61K31/7016
- IPC: A61K31/7016 ; A61K39/395 ; C07H11/04 ; A61K31/7028 ; A61K45/06 ; C07H13/04 ; C07K16/28 ; A61K31/7024 ; A61N5/10 ; A61K39/00
Abstract:
The present disclosure relates generally to compositions and methods for treating cancer with a glucopyranosyl lipid A (GLA) in the absence of antigen.
Public/Granted literature
- US20190269714A1 GLA Monotherapy for use in Cancer Treatment Public/Granted day:2019-09-05
Information query
